🇺🇸 FDA
Patent

US 9365621

Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation

granted A61KA61K38/00A61K38/08

Quick answer

US patent 9365621 (Method for preventing neoplastic transformation by inhibition of retinoblastoma protein inactivation) held by The Regents of the University of California expires Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Jun 14 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 09 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K38/00, A61K38/08, A61P, A61P35/00